Pharmacopoeia and Drug Labeling Translation: Compliance Strategies for SmPC, PIL, and Drug Registration

Introduction: The Pain Points of Translation in Drug Registration

In the global drug registration process, the accuracy of pharmacopoeia and drug labeling translation directly impacts review timelines and patient safety. A single mistranslated term can lead to a deficiency letter for your CTD/eCTD dossier, or even delay market approval. For instance, the EU EMA requires SmPC (Summary of Product Characteristics) and PIL (Patient Information Leaflet) to be in the official language of each member state, with terminology aligned to EDQM standards. However, many companies face repeated submissions due to inconsistent translations and format non-compliance, resulting in millions of euros in losses.

Core Regulatory Requirements for Pharmacopoeia and Drug Labeling Translation

EU: MDR/IVDR and SmPC/PIL

Under EU MDR 2017/745 and IVDR 2017/746, instructions for medical devices and IVDs must be translated into the official language of the destination country. For pharmaceuticals, Directive 2001/83/EC mandates SmPC as the core registration document, and PIL must be presented in a clear Q&A format. Translation must ensure:

• Terminology consistency with Ph. Eur. (European Pharmacopoeia);
• Zero errors in dosage, indications, contraindications;
• Format compliance with QRD templates.

US: FDA 510(k) and USPI

The FDA requires prescription drug labeling (USPI) to follow 21 CFR 201.57, with translations adhering to PLR format. For generics, labeling must match the RLD (Reference Listed Drug).

China: NMPA and Pharmacopoeia

The Chinese Pharmacopoeia (ChP) is the legal standard for drug registration. Translations of imported drug labels must align with NMPA templates and be submitted in CTD format.

Key Challenges in Pharmacopoeia and Drug Labeling Translation

Terminology Standardization and Consistency

Pharmacopoeia terms (e.g., "Assay" for "含量测定") must be strictly unified. We recommend building a termbase and referencing international standards like MedDRA and WHODrug.

Regulatory Format Adaptation

Labeling formats vary significantly across countries. For example, EU PIL requires specific symbols and font sizes, while Japanese PIL uses a mix of Kanji and Kana.

CTD/eCTD Structured Submission

Translations in eCTD Module 1 (administrative) and Module 2 (CTD summaries) must comply with ICH M4 specifications, with PDFs supporting bookmarks and hyperlinks.

Key Terminology Cross-Reference

English	Chinese	Definition
SmPC	药品特性概要	EU core drug registration document detailing indications, dosage, pharmacology, etc.
PIL	患者信息说明书	Patient-facing leaflet, presented in Q&A format.
CTD	通用技术文档	Common Technical Document, organized into 5 modules.
eCTD	电子通用技术文档	Electronic version of CTD for online submission and review.
Ph. Eur.	欧洲药典	Legal source of drug quality standards in Europe.
MedDRA	监管活动医学词典	Standardized terminology for adverse event reporting.
QRD	质量审查文档	EU template for product information.
USPI	美国处方药说明书	FDA-required prescription drug labeling.

Best Practices Checklist for Pharmacopoeia and Drug Labeling Translation

• Establish a project termbase to ensure consistency of pharmacopoeia terms with SmPC/PIL.
• Use CAT tools (e.g., Trados, MemoQ) with QA checks enabled.
• Translate by native speakers and review by a second linguist.
• Follow target market regulatory formats (e.g., QRD, PLR).
• Validate eCTD PDF bookmarks, hyperlinks, and font embedding.
• Perform back translation to verify critical information.
• Maintain translation memory for future updates.

Frequently Asked Questions (FAQ)

Q1: Is certification required for drug labeling translation?
A: Yes. According to ISO 17100:2015, translation services must be performed by qualified translators and reviewed. For drug registration, we recommend choosing a translation company certified under ISO 9001 and ISO 27001 to ensure quality and information security.

Q2: How to handle layout issues for multilingual PILs?
A: Use DTP tools like Adobe InDesign and follow QRD templates. For complex scripts (e.g., Arabic, Thai), ensure font embedding and correct text direction.

Q3: What to do when encountering new terms in pharmacopoeia translation?
A: Refer to official terminology from ICH, WHO, or the target country's pharmacopoeia. If no equivalent exists, consult regulatory authorities or use industry consensus translations, and document them in the termbase.

Conclusion: Strategic Takeaways

Pharmacopoeia and drug labeling translation is not just language conversion; it is the core of regulatory compliance and patient safety. Companies should establish standardized processes, partner with ISO-certified translation providers, and leverage termbases and CAT tools to improve efficiency. WorldLingo (语家翻译) specializes in life sciences and provides translation services compliant with ISO 17100, ISO 9001, and ISO 27001, helping your drugs achieve global registration faster. Contact us for a customized quote.